Institute of Microbiology, ETH Zürich, Vladimir-Prelog-Weg 4, 8093 Zürich, Switzerland.
Institute of Biochemistry, ETH Zürich, Otto-Stern-Weg 3, 8093 Zürich, Switzerland.
Sci Immunol. 2019 Apr 12;4(34). doi: 10.1126/sciimmunol.aav1730.
Asymmetric partitioning of fate determinants is a mechanism that contributes to T cell differentiation. However, it remains unclear whether the ability of T cells to divide asymmetrically is influenced by their differentiation state, as well as whether enforcing asymmetric cell division (ACD) rates would have an impact on T cell differentiation and memory formation. Using the murine LCMV infection model, we established a correlation between cell stemness and the ability of CD8 T cells to undergo ACD. Transient mTOR inhibition was proven to increase ACD rates in naïve and memory cells and to install this ability in exhausted CD8 T cells. Functionally, enforced ACD correlated with increased memory potential, leading to more efficient recall response and viral control upon acute or chronic LCMV infection. Moreover, transient mTOR inhibition also increased ACD rates in human CD8 T cells. Transcriptional profiling revealed that progenies emerging from enforced ACD exhibited more pronounced early memory signatures, which functionally endowed these cells with better survival in the absence of antigen exposure and more robust homing to secondary lymphoid organs, providing critical access to survival niches. Our data provide important insights into how ACD can improve long-term survival and function of T cells and open new perspectives for vaccination and adoptive T cell transfer therapies.
命运决定因素的不对称分配是促进 T 细胞分化的一种机制。然而,目前尚不清楚 T 细胞是否能够不对称分裂的能力是否受到其分化状态的影响,以及强制不对称细胞分裂 (ACD) 率是否会对 T 细胞分化和记忆形成产生影响。我们使用小鼠 LCMV 感染模型,建立了 CD8 T 细胞发生 ACD 的能力与细胞干性之间的相关性。事实证明,短暂抑制 mTOR 可增加幼稚和记忆细胞的 ACD 率,并在耗竭的 CD8 T 细胞中安装这种能力。功能上,强制 ACD 与增加记忆潜能相关,导致在急性或慢性 LCMV 感染时更有效地进行回忆反应和病毒控制。此外,短暂抑制 mTOR 还可增加人 CD8 T 细胞的 ACD 率。转录谱分析显示,强制 ACD 产生的后代表现出更明显的早期记忆特征,这些特征赋予这些细胞在没有抗原暴露的情况下更好的生存能力,并更强烈地归巢到次级淋巴器官,为生存龛提供了关键的访问途径。我们的数据提供了关于 ACD 如何改善 T 细胞的长期存活和功能的重要见解,并为疫苗接种和过继性 T 细胞转移治疗开辟了新的视角。